PubMed · 1996 · 17 citations · 0 references
MedicineHematologyOncologyImmunotherapyStem Cell TransplantationBone Marrow Transplant PharmacotherapyEngraftment MonitoringHematopoietic Stem Cell TransplantationMyeloid-derived Suppressor CellsMyelosuppression ManagementTransplant SurvivalMyeloablative ChemotherapyNeuroblastoma BiologyRefractory Neuroblastoma
Current results suggest that purged autologous bone marrow transplant may improve outcome for some subsets of high risk neuroblastoma, but the risk of relapse is still high.